Human Tumor Sequencing Project

This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Cancer Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Scripps Translational Science Institute

La Jolla, California, 92037, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diagnosis of a solid tumor or blood borne cancer
18 years or older
Eligible to have blood drawn

Treatment and study plan

Primary outcomes

Determine biomarkers of clinical utility and copy number variants through genetic analysis.

Time frame: four years

Sponsors and collaborators

Lead sponsor

Scripps Translational Science Institute

Other

Registry information

Acronym: HuTS

Important dates

Study start: 2010
Primary completion: 2014
Study completion: 2014
First posted: May 31, 2012
Registry last updated: Nov 18, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed